Aemetis Inc. (AMTX) Downgraded to “Sell” at Zacks Investment Research
According to Zacks, “Aemetis, Inc. is an advanced fuels and renewable chemicals company. It produces renewable chemicals and fuels using patented microbes and processes. Aemetis owns and operates an ethanol animal feed plant in California to produce D5 Advanced Biofuels using the sorghum/biogas/CHP pathway. The Company also built, owns, and operates a renewable chemicals and advanced fuels production facility on the East Coast of India producing high quality, distilled biodiesel and refined glycerin for customers in Europe and Asia. Aemetis, Inc. is headquartered in Cupertino, California. “
Separately, FBR & Co reissued a hold rating and issued a $1.75 price target on shares of Aemetis in a report on Thursday, September 8th.
Shares of Aemetis (NASDAQ:AMTX) opened at 1.30 on Wednesday. Aemetis has a 12-month low of $1.01 and a 12-month high of $3.05. The stock’s market cap is $25.82 million. The stock has a 50 day moving average price of $1.38 and a 200-day moving average price of $2.04.
Aemetis (NASDAQ:AMTX) last posted its quarterly earnings data on Thursday, August 11th. The company reported ($0.25) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.26) by $0.01. The firm had revenue of $33.10 million for the quarter, compared to analyst estimates of $38.10 million. Equities analysts anticipate that Aemetis will post ($1.04) EPS for the current fiscal year.
Aemetis Company Profile
Aemetis, Inc is an international renewable fuels and biochemicals company. The Company is focused on the production of fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into biorefineries.
Receive News & Stock Ratings for Aemetis Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis Inc. and related stocks with our FREE daily email newsletter.